Bristol Myers Squibb · 3 weeks ago
Reference Standard and Critical Reagents Scientist Co-op
Bristol Myers Squibb is a leading biopharmaceutical company dedicated to transforming patients' lives through science. They are seeking a highly motivated undergraduate scientist for a co-op position within the Reference Standard and Critical Reagents team, where the candidate will support operational projects and laboratory activities at the New Brunswick, NJ site.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Assisting Project Managers and learning skills including laboratory data review and interpretation, supply chain, business documentation, and influencing across a matrixed network
Laboratory data entry into the RSCR Inventory database
Reviewing material’s Safety Data Sheets (SDS) and updating RSCR records with any discrepancies found
Assisting with laboratory activities as needed
Report directly to the Senior Managers of RSCR on a regular basis to update on the progress of work achieved
Qualification
Required
BS student majoring in any degree, preference given to a science or engineering student
Ability to work on-site at BMS's New Brunswick, NJ campus a must
Excellent communication skills, both written and verbal are required
Ability to work independently and effectively collaborate with cross-functional teams
All candidates must be authorized to work in the US both at the time of hire and for the duration of their employment
Benefits
Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Recent News
2026-01-25
The Motley Fool
2026-01-24
Company data provided by crunchbase